共查询到19条相似文献,搜索用时 0 毫秒
1.
Monica Terenziani MD Paolo D'Angelo MD Alessandro Inserra MD Renata Boldrini MD Gianni Bisogno MD Gian Luca Babbo MD Massimo Conte MD Patrizia Dall' Igna MD Maria Debora De Pasquale MD Paolo Indolfi MD Luigi Piva MD Giovanna Riccipetitoni MD Fortunato Siracusa MD Filippo Spreafico MD Paolo Tamaro MD Giovanni Cecchetto MD 《Pediatric blood & cancer》2015,62(7):1202-1208
2.
3.
Comparison of in‐patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group 下载免费PDF全文
Kelly D. Getz PhD Yimei Li PhD Todd A. Alonzo PhD Matthew Hall PhD Robert B. Gerbing MA Lillian Sung MD PhD Yuan‐Shung Huang MS Staci Arnold MD MBA Alix E. Seif MD MPH Tamara P. Miller MD Rochelle Bagatell MD Brian T. Fisher DO MSCE Peter C. Adamson MD Alan Gamis MD MPH Ron Keren MD Richard Aplenc MD PhD 《Pediatric blood & cancer》2015,62(10):1775-1781
4.
Termuhlen AM Smith LM Perkins SL Lones M Finlay JL Weinstein H Gross TG Abromowitch M 《Pediatric blood & cancer》2012,59(7):1229-1233
5.
Jennifer Seelisch Lillian Sung Michael J. Kelly Jennifer L. Raybin Melissa Beauchemin Christopher C. Dvorak Katherine Patterson Kelly Michael L. Nieder Robert B. Noll Jennifer Thackray Nicole J. Ullrich Sandra Cabral L. Lee Dupuis Paula D. Robinson 《Pediatric blood & cancer》2019,66(1)
Providing evidence‐based supportive care for children with cancer has the potential to optimize treatment outcomes and improve quality of life. The Children's Oncology Group (COG) Supportive Care Guidelines Subcommittee conducted a systematic review to identify current supportive care clinical practice guidelines (CPGs) relevant to childhood cancer or pediatric hematopoietic stem cell transplant. Only 22 papers met the 2011 Institute of Medicine criteria to be considered a CPG. The results highlight the paucity of CPGs available to pediatric oncology healthcare professionals and the pressing need to create CPGs using current methodological standards. 相似文献
6.
Elevated pretransplant pulmonary vascular resistance index does not predict mortality after isolated orthotopic heart transplantation in children: A retrospective analysis of the UNOS database 下载免费PDF全文
Peter Chiu Justin M. Schaffer Ahmad Y. Sheikh Richard Ha Olaf Reinhartz Richard Mainwaring Bruce A. Reitz 《Pediatric transplantation》2015,19(6):623-633
OHT is the definitive therapy in end‐stage heart failure. Elevated PVRI is considered a relative contraindication to isolated OHT; this assumption is re‐evaluated using data from the UNOS database. A retrospective review of de‐identified data from the UNOS dataset was performed. There were 1943 pediatric OHT recipients between 10/87 and 12/11 with sufficient data for analysis. Cox regression was performed to examine the effect of baseline characteristics on post‐transplant survival. Patients were propensity matched, and Kaplan–Meier survival analysis was performed comparing cohorts of patients using thresholds of 6 and 9 WU × m2. PVRI was not a significant predictor of post‐transplant outcomes in either univariate or multivariate Cox regression. Kaplan–Meier analysis revealed no difference in survival between both unmatched and propensity‐matched OHT recipients. In conclusion, elevated PVRI was not associated with post‐transplant mortality in pediatric OHT recipients. A prospective study assessing the current use of PVRI ≥6 as a threshold to contraindicate isolated OHT should be undertaken. Removing this potentially unnecessary restriction on transplant candidacy may make this life‐saving therapy available to a greater number of patients. 相似文献
7.
A cross‐sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry 下载免费PDF全文
Bimota Nambam Janet Silverstein Peiyao Cheng Katrina J Ruedy Roy W Beck R Paul Wadwa Georgeanna Klingensmith Steven M Willi Jamie R Wood Fida Bacha Inas H Thomas William V Tamborlane for the Pediatric Diabetes Consortium 《Pediatric diabetes》2017,18(3):222-229
8.
9.
10.
11.
12.
A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high‐risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group 下载免费PDF全文
Adam J. Esbenshade Mehmet Kocak Linda Hershon Pierre Rousseau Jean‐Claude Decarie Susan Shaw Peter Burger Henry S. Friedman Amar Gajjar Albert Moghrabi 《Pediatric blood & cancer》2017,64(6)
13.
14.
Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the Third International Central Nervous System (CNS) Germ Cell Tumor (GCT) Study 下载免费PDF全文
Rachel Pruitt BS Nasjla S. DaSilva MD Andrea Cappellano MD Clara Belessiotis MB ChB Blanca Diez MD Sharon Gardner MD Jeffrey Allen MD Mark Weinblatt MD Nicholas Gottardo MD Girish Dhall MD Jonathan L. Finlay MB ChB 《Pediatric blood & cancer》2015,62(11):1920-1924
15.
Comparison of administrative/billing data to expected protocol‐mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group 下载免费PDF全文
Tamara P. Miller MD Andrea B. Troxel ScD Yimei Li PhD Yuan‐Shung Huang MS Todd A. Alonzo PhD Robert B. Gerbing MA Matt Hall PhD Kari Torp Brian T. Fisher DO MSCE Rochelle Bagatell MD Alix E. Seif MD MPH Lillian Sung MD PhD Alan Gamis MD MPH David Rubin MD MSCE Selina Luger MD Richard Aplenc MD PhD 《Pediatric blood & cancer》2015,62(7):1184-1189
16.
Phase 1 trial of ontuxizumab (MORAb‐004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213) 下载免费PDF全文
Robin E. Norris Elizabeth Fox Joel M. Reid Andrew Ralya Xiaowei W. Liu Charles Minard Brenda J. Weigel 《Pediatric blood & cancer》2018,65(5)
17.
18.
19.
Desalegn Kuche Cami Moss Solomon Eshetu Girmay Ayana Mihretab Salasibew Alan D. Dangour Elizabeth Allen 《Maternal & child nutrition》2020,16(1)
Infants and young children need diets high in nutrient density and diversity to meet the requirements of rapid growth and development. Our aim was to evaluate sociodemographic, agricultural diversity, and women's empowerment factors associated with child dietary diversity and length‐for‐age z‐score (LAZ) in children 6–23 months using data collected as part of the Sustainable Undernutrition Reduction in Ethiopia (SURE) evaluation study baseline survey in May–June 2016. We here present a novel analysis using directed acyclic graphs (DAGs) to represent our assumptions about the causal influences between the factors of interest and the outcomes. The causal diagrams enabled the identification of variables to be included in multivariable analysis to estimate the total effects of factors of interest using ordinal logistic/linear regression models. We found that child dietary diversity was positively associated with LAZ with children consuming 4 or more food groups having on average an LAZ score 0.42 (95% CI [0.08, 0.77]) higher than those consuming no complementary foods. Household production of fruits and vegetables was associated with both increased child dietary diversity (adjusted OR 1.16; 95% CI [1.09, 1.24]) and LAZ (adjusted mean difference 0.05; 95% CI [0.005, 0.10]). Other factors positively associated with child dietary diversity included age in months, socio‐economic status, maternal education, women's empowerment and dietary diversity, paternal childcare support, household food security, fruit and vegetable cultivation, and land ownership. LAZ was positively associated with age, socio‐economic status, maternal education, fruit and vegetable production, and land ownership. 相似文献